PFKFB3 and hepatocellular carcinoma: Elevated PFKFB3 is generally associated with poor outcomes and worse clinical manifestations; therefore, regulating PFKFB3 could not merely inhibit the activity of PFK to target glycolysis, more than arrest cell cycle and cell death in HCC.